Connecting supply chains in new ways for pharma and healthcare

In twenty years, when we look back on the evolution of global supply chains, people will see two very distinct periods – pre-COVID-19 and post-COVID-19. Yes, there have been viruses before, but none in our modern, globalised world, where cross-border trade comprises 50% of GDP. We have never had a supply chain that contains so many moving parts across so many countries with so many stakeholders involved. And that supply chain has never been put under the pressure it has recently, unless you count the theoretical exercises or disaster plans of academics and risk-managers.

In areas like pharmaceuticals and healthcare, professionals are balancing this need for reactive response with designing a more reliable, transparent, intelligent future for their supply chains. To effect change, these businesses need to assess the entire chain, from manufacture to delivery, to customs, to storage, to end customer.

In this eBook we assess the latest innovations and evolutions and evaluate what the future might look like for pharmaceutical and healthcare logistics as a whole. We highlight some of the key areas where Maersk is driving end-to-end innovation via evolutions in processes, technology, and collaboration.